Thursday, June 08, 2023  |


Kendall Holt’s statement

Fighters Network

Former welterweight titleholder Kendall Holt released a statement through his promoter, Gary Shaw Productions, on Friday, which commented on the “Atypical finding” drug test result following his Feb. 22 IBF title bout with Lamont Peterson:

“First and foremost, I want everyone to know that I did not knowingly take any P.E.D., nor do I believe I unknowingly took any P.E.D.

The facts are as follows:

My camp, at my instruction, requested WADA level testing in connection with my bout with Lamont Peterson. Post bout urine samples were sent to the WADA accredited laboratory testing lab in Salt Lake City.

We repeatedly attempted to obtain the lab results from the D.C. Commission, with no success until yesterday. We did, however, receive an email from the Commission stating that both fighters had passed their test. Nonetheless we wanted the actual lab results.

Yesterday we received those lab results. The lab results were not identified by fighter but one of the results showed an elevated HCG level. It was labeled as an ‘Atypical Finding.’

There are three levels of findings for WADA testing. There is a ‘negative’ finding, meaning that the athlete has tested ‘negative’ for prohibited substances, there is an ‘Adverse Analytical Finding,’ meaning that there is a prohibited substance, and there is an ‘Atypical Finding,’ meaning there should be further investigation. In part this is because there are certain medical conditions, which can cause elevated HCG levels.

We briefly believed that the test involved was that of Mr. Peterson. In fact it may be mine.

At this point, we do not have a full chain of custody report, which we will obtain. We will also, once the full chain of custody report is obtained, have the ‘B’ sample tested. Finally, when that is completed we will have the medical tests as indicated by the results.”